Curcumin (diferuloylmethane) inhibition of tumor necrosis factor (TNF)- mediated adhesion of monocytes to endothelial cells by suppression of cell surface expression of adhesion molecules and of nuclear factor-κB activation

Biochemical Pharmacology

Volumn 55, Issue 6, 1998, Pages 775-783

  Kumar, Ashok ^d   Dhawan, Subhash ^a   Hardegen, Neil J ^b   Aggarwal, Bharat B ^c  

^a CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

^b NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^d NONE

Author keywords

Adhesion proteins; Curcumin; Endothelial cells; NF B; TNF

Indexed keywords

CELL ADHESION MOLECULE; CURCUMIN; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; TUMOR NECROSIS FACTOR; VASCULAR CELL ADHESION MOLECULE 1;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; ATHEROGENESIS; CELL SURFACE; CELL VIABILITY; CONTROLLED STUDY; ELECTROPHORETIC MOBILITY; HUMAN; HUMAN CELL; LEUKOCYTE ADHERENCE; METASTASIS; MONOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEPSIS; UMBILICAL VEIN; VASCULAR ENDOTHELIUM;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIBODIES; CELL ADHESION; CELL ADHESION MOLECULES; CELL MEMBRANE; CURCUMIN; DEPRESSION, CHEMICAL; E-SELECTIN; ENDOTHELIUM, VASCULAR; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; MONOCYTES; NF-KAPPA B; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR CELL ADHESION MOLECULE-1;

EID: 0032520716     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(97)00557-1     Document Type: Article

References (53)

1. Govindarajan VS. Turmeric-chemistry, technology and quality. Crit Rev Food Sci Nutr. 12:1980;199-301.
2. Rao CV, Rivenson A, Simi B, Reddy BS. Chemoprevention of colon carcinogenesis by dietary curcumin, a naturally occurring plant phenolic compound. Cancer Res. 55:1995;259-266.
3. Satoskar RR, Shah SJ, Shenoy SG. Evaluation of anti-inflammatory property of curcumin (diferuloyl methane) in patients with postoperative inflammation. Int J Clin Pharmacol Ther Toxicol. 24:1986;651-654.
4. Tanaka T, Makita H, Ohnishi M, Hirose Y, Wang A, Mori H, Satoh K, Hara A, Ogawa H. Chemoprevention of 4-nitroquinoline 1-oxide-induced oral carcinogenesis by dietary curcumin and hesperidin Comparison with the protective effect of β-carotene . Cancer Res. 54:1994;4653-4659.
5. Huang MT, Lou YR, Ma W, Newmark HL, Reuhl KR, Conney AH. Inhibitory effects of dietary curcumin on forestomach, duodenal, and colon carcinogenesis in mice. Cancer Res. 54:1994;5841-5847.
6. Huang MT, Smart RC, Wong CQ, Conney AH. Inhibitory effect of curcumin, chlorogenic acid, caffeic acid, and ferulic acid on tumor promotion in mouse skin by 12-O-tetradecanoylphorbol-13-acetate. Cancer Res. 48:1988;5941-5946.
7. Huang MT, Lysz T, Ferraro T, Abidi TF, Laskin JD, Conney AH. Inhibitory effects of curcumin on in vitro lipoxygenase and cyclooxygenase activities in mouse epidermis. Cancer Res. 51:1991;813-819.
8. Flynn DL, Rafferty MF, Boctor AM. Inhibition of 5-hydroxy-eicosatetraenoic acid (5-HETE) formation in intact human neutrophils by naturally-occurring diarylheptanoids Inhibitory activities of curcuminoids and yakuchinones . Prostaglandins Leukot Med. 22:1986;357-360.
9. Li CJ, Zhang LJ, Dezube BJ, Crumpacker CS, Pardee AB. Three inhibitors of type 1 human immunodeficiency virus long terminal repeat-directed gene expression and virus replication. Proc Natl Acad Sci USA. 90:1993;1839-1842.
10. Singh S, Aggarwal BB. Activation of transcription factor NF-κB is suppressed by curcumin (diferuloylmethane). J Biol Chem. 270:1995;24995-25000.
11. Chan MM. Inhibition of tumor necrosis factor by curcumin, a phytochemical. Biochem Pharmacol. 49:1995;1551-1556.
12. Aggarwal BB, Natarajan K. Tumor necrosis factor Developments during last decade . Eur Cytokine Netw. 7:1996;93-124.
13. Grau GE, Lou J. TNF in vascular pathology The importance of platelet-endothelium interactions . Res Immunol. 144:1993;355-363.
14. Pober JS, Cotran RS. Cytokines and endothelial biology. Physiol Rev. 70:1990;427-451.
15. Collins T, Read MA, Neish AS, Whithy MZ, Thanos D, Maniatis T. Transcriptional regulation of endothelial cell adhesion molecules NF-κB and cytokine-inducible enhancers . FASEB J. 9:1995;899-909.
16. Baeuerle PA, Henkel T. Function and activation of NF-κB in the immune system. Annu Rev Immunol. 12:1994;141-179.
17. Chaturvedi MM, LaPushin R, Aggarwal BB. Tumor necrosis factor and lymphotoxin Qualitative and quantitative differences in the mediation of early and late cellular response . J Biol Chem. 269:1994;14575-14583.
18. Lafrenie RM, Wahl LM, Epstein JS, Hewlett IK, Yamada KM, Dhawan S. HIV-1-tat modulates the function of monocytes and alters their interactions with microvessel endothelial cells. J Immunol. 156:1996;1638-1645.
19. Carlos T, Kovach N, Schwartz B, Rosa M, Newman B, Wayner E, Benjamin C, Osborn L, Lobb R, Harlan J. Human monocytes bind to two cytokine-induced adhesive ligands on cultured human endothelial cells Endothelial-leukocyte adhesion molecule-1 and vascular cell adhesion molecule-1 . Blood. 77:1991;2266-2271.
20. Voraberger G, Schafer R, Stratowa C. Cloning of the human gene for intercellular adhesion molecule 1 and analysis of its 5′-regulatory region. Induction by cytokines and phorbol ester. J Immunol. 147:1991;2777-2786.
21. Thanos D, Maniatis T. NF-κB A lesson in family values . Cell. 80:1995;529-532.
22. Meichle A, Schütze S, Hensel G, Brunsing D, Krönke M. Protein kinase C-independent activation of nuclear factor κB by tumor necrosis factor. J Biol Chem. 265:1990;8339-8343.
23. Cordle S, Donald R, Read MA, Hawiger J. Lipopolysaccharide induces phosphorylation of MAD3 and activation of c-Rel and related NF-κB proteins in human monocytic THP-1 cells. J Biol Chem. 268:1993;11803-11810.
24. Johnson DR, Douglas I, Jahnke A, Ghosh S, Pober JS. A sustained reduction of in IκB-β may contribute to persistent NF-κB activation in human endothelial cells. J Biol Chem. 271:1996;16317-16322.
25. Dhawan S, Weeks B, Soderland C, Schnaper H, Toro L, Asthana S, Hewlett I, Stetler-Stevenson W, Yamada S, Yamada K, Meltzer M. HIV infection alters monocyte interactions with human microvascular endothelial cells. J Immunol. 154:1995;422-432.
26. Springer TA. Adhesion receptors of the immune system. Nature. 346:1990;425-434.
27. Wegner CD, Gundel RH, Reilly P, Haynes N, Letts LG, Rothlein R. Intercellular adhesion molecule-1 (ICAM-1) in the pathogenesis of asthma. Science. 247:1990;456-459.
28. Schleimer TRP, Rutledge BK. Cultured human vascular endothelial cells acquire adhesiveness for neutrophils after stimulation with interleukin 1, endotoxin, and tumor-promoting phorbol diesters. J Immunol. 136:1986;649-654.
29. Iademarco MF, McQuillan JJ, Rosen GD, Dean DC. Characterization of the promoter for vascular cell adhesion molecule-1 (VCAM-1). J Biol Chem. 267:1992;16323-16329.
30. Schindler U, Baichwal VR. Three NF-κB binding sites in the human E-selectin gene required for maximal tumor necrosis factor alpha-induced expression. Mol Cell Biol. 14:1994;5820-5831.
31. Cockerill GW, Bert AG, Ryan GR, Gamble JR, Vadas MA, Cockerill PN. Regulation of granulocyte-macrophage colony-stimulating factor and E-selectin expression in endothelial cells by cyclosporin A and the T-cell transcription factor NFAT. Blood. 86:1995;2689-2698.
32. Wölle J, Ferguson E, Keshava C, Devall LJ, Boschelli DH, Newton RS, Saxena U. Inhibition of tumor necrosis factor induced human aortic endothelial cell adhesion molecule gene expression by an alkoxybenzo[b]thiophene-2-carboxamide. Biochem Biophys Res Commun. 214:1995;6-10.
33. Masamune A, Hakomori S-I, Igarashi Y. N,N,N-Trimethylsphingosine inhibits interleukin-1β-induced NF-κB activation and consequent E-selectin expression in human umbilical vein endothelial cells. FEBS Lett. 367:1995;205-209.
34. Chen CC, Rosenbloom CL, Anderson DC, Manning AM. Selective inhibition of E-selectin, vascular cell adhesion molecule-1, and intercellular adhesion molecule-1 expression by inhibitors of IκB-α phosphorylation. J Immunol. 155:1995;3538-3545.
35. Cobb RR, Felts KA, Parry GCN, Mackman N. Proteasome inhibitors block VCAM-1 and ICAM-1 gene expression in endothelial cells without affecting nuclear translocation of nuclear factor-κB. Eur J Immunol. 26:1996;839-845.
36. Ferran C, Millan MT, Csizmadia V, Cooper JT, Brostjan C, Bach FH, Winkler H. Inhibition of NF-κB by pyrrolidine dithiocarbamate blocks endothelial cell activation. Biochem Biophys Res Commun. 214:1995;212-223.
37. Pober JS, Slowik MR, De Luca LG, Ritchie JA. Elevated cyclic AMP inhibits endothelial cell synthesis and expression of TNF-induced endothelial leukocyte adhesion molecule-1 and vascular cell adhesion molecule-1, but not intercellular adhesion molecule-1. J Immunol. 150:1993;5114-5123.
38. Weber C, Negrescu E, Erl W, Pietsch A, Frankenberger M, Ziegler-Heitbrock HW, Siess W, Weber PC. Inhibitors of protein tyrosine kinase suppress TNF-stimulated induction of endothelial cell adhesion molecules. J Immunol. 155:1995;445-451.
39. Dao T, Iwaki K, Takeuchi M, Ohashi K, Fukuda S, Kurimoto M. Natural human interferon-α inhibits the adhesion of a human carcinoma cell line to human vascular endothelium. J Interferon Cytokine Res. 15:1995;869-876.
40. Autier MV, Yue T-L, Ferstein GZ, Ohlstein E. Antisense oligonucleotides to the p65 subunit of NF-κB inhibit human vascular smooth muscle cell adherence and proliferation and prevent neointima formation in rat carotid arteries. Biochem Biophys Res Commun. 213:1995;827-836.
41. De Caterina R, Libby P, Peng HB, Thannickal VJ, Rajavashisth TB, Gimbrone MA Jr, Shin WS, Liao JK. Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines. J Clin Invest. 96:1995;60-68.
42. Khachigian LM, Collins T, Fries JWU. Nuclear factor-κB mediates induction of vascular cell adhesion molecule-1 in glomerular mesangial cells. Biochem Biophys Res Commun. 206:1995;462-467.
43. Reddy S, Aggarwal BB. Curcumin is a non-competitive and selective inhibitor of phosphorylase kinase. FEBS Lett. 341:1994;19-22.
44. Mazumder A, Raghavan K, Weinstein J, Kohn KW, Pommier Y. Inhibition of human immunodeficiency virus type-1 integrase by curcumin. Biochem Pharmacol. 49:1995;1165-1170.
45. Xu YX, Pindolia KR, Janakiraman N, Noth CJ, Chapman RA, Gautam SC. Curcumin, a compound with anti-inflammatory and anti-oxidant properties, down-regulates chemokine expression in bone marrow stromal cells. Exp Hematol. 25:1997;413-422.
46. +2 ion and cellular p53 protein by curcumin in colorectal carcinoma cells. Mol Carcinog. 17:1996;224-234.
47. Hasmeda M, Polya GM. Inhibition of cyclic AMP-dependent protein kinase by curcumin. Phytochemistry. 42:1996;599-605.
48. Pereira MA, Grubbs CJ, Barnes LH, Li H, Olson GR, Eto I, Juliana M, Whitaker LM, Kelloff GJ, Steele VE, Lubet RA. Effects of the phytochemicals, curcumin and quercetin, upon azoxymethane-induced colon cancer and 7,12-dimethylbenz[a]anthracene-induced mammary cancer in rats. Carcinogenesis. 17:1996;1305-1311.
49. Thresiamma KC, George J, Kuttan R. Protective effect of curcumin, ellagic acid and bixin on radiation induced toxicity. Indian J Exp Biol. 34:1996;845-847.
50. 2 formation. J Biol Chem. 271:1996;31496-31501.
51. Kazmi SM, Plante RK, Visconti V, Taylor GR, Zhou L, Lau CY. Suppression of NF kappa B activation and NF kappa B-dependent gene expression by tepoxalin, a dual inhibitor of cyclooxygenase and 5-lipoxygenase. J Cell Biochem. 57:1995;299-310.
52. Arakawa T, Nakamura M, Yoshimoto T, Yamamoto S. The transcriptional regulation of human arachidonate 12-lipoxygenase gene by NFκB/Rel. FEBS Lett. 363:1995;105-110.
53. Sato H, Seiki M. Regulatory mechanism of 92 kDa type IV collagenase gene expression which is associated with invasiveness of tumor cells. Oncogene. 8:1993;395-405.